Bonus BioGroup Ltd. (BONS.TA)
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.
26.60+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+10.4%
The outlook
Bonus BioGroup Ltd. currently reads as bearish based on below its 50- & 200-day averages, 14% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Market cap
$310.7M
52-wk high
60.90
52-wk low
21.00
50-day avg
32.26
200-day avg
35.46
Trailing P/E
—